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Abstract 
 
Neurodegenerative diseases such as Parkinson’s and amyotrophic lateral 
sclerosis have devastating consequences to the afflicted patients. A major cellular 
pathophysiology underlying these diseases is mitochondrial oxidative stress (MOS) 
leading to neuronal death. Here, we investigated the neuroprotective effects of a 
novel class of nutraceuticals, anthocyanins, against MOS-induced death in primary 
cultures of rat cerebellar granule neurons (CGNs). Anthocyanins are natural 
antioxidants whose neuroprotective potential has yet to be examined in detail. 
Kuromanin and callistephin are anthocyanins derived from black rice and 
strawberries, respectively. Glutathione (GSH)-sensitive MOS and intrinsic apoptosis 
were induced in CGNs by the Bcl-2 inhibitor, HA14-1. Callistephin and kuromanin 
each demonstrated significant neuroprotection from this MOS-induced death that 
was equal to that provided by the green tea polyphenol, epigallocatechin 3-gallate; 
however, neither anthocyanin was as effective as GSH at rescuing CGNs. Incubation 
with HA14-1 alone resulted in nearly 90% apoptosis of CGNs and either callistephin 
or kuromanin reduced this effect to approximately 20% cell death. Treatment with 
HA14-1 caused a marked depletion of mitochondrial GSH in CGNs to approximately 
40% of the control level. Callistephin and kuromanin essentially prevented the 
reduction in this critical pool of endogenous antioxidant. These data indicate that 
callistephin and kuromanin represent a new class of neuroprotective compounds 
 iii 
that warrant further study as possible therapeutic agents for the treatment of 
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Chapter One: Introduction 
Neurodegenerative disease 
There are a wide variety of neurodegenerative diseases with different 
symptoms and pathologies. For example, Parkinson’s disease (PD) attacks 
dopaminergic neurons of the substantia nigra pars compacta while amyotrophic 
lateral sclerosis (ALS) manifests itself in the degeneration of motor neurons. 
Alzheimer’s disease (AD) hallmarks are amyloid plaques and neurofibrillary tangles 
in the brain and multiple sclerosis (MS) is a progressive demyelinating disease. All 
four of these diseases are prominent in the public eye and often portrayed as 
unrelated to each other, when in reality the cellular mechanisms behind them are 
likely the same. The strong majority of cases are sporadic, without a genetic link, so 
the challenge is to figure out what causes neurodegeneration so that it can be 
prevented or slowed. Oxidative stress is thought to be a common link in 
neurodegenerative disease and is a liable mechanism in aging as well [1]. Many 
studies have been conducted showing links between oxidative stress and PD [2, 3], 
AD [4-6], ALS [7, 8], and MS [9] to highlight a few.  
Neurons are especially susceptible to oxidative stress because they lack the 
6-phosphofructo-2-kinase pathway (PFK2) to regulate glycolysis [10]. Therefore, 
neurons are reliant on mitochondrial oxidative phosphorylation for energy because 
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they cannot up-regulate glycolysis in times when oxygen is scarce. Additionally, 
mature neurons no longer participate in the cell cycle, which makes them vulnerable 
to oxidative stress-induced apoptosis. Therefore, neurons cannot enter the cell cycle 
to replace neurons that have died. Since there are a fixed number of neurons, those 
that undergo apoptosis are lost forever. This, along with neuronal dependence on 
mitochondrial oxidative phosphorylation energy production creates a unique 
vulnerability to oxidative stress-induced apoptosis. The brain’s dependence on 
oxygen is even more apparent by the fact it uses approximately 20% of the body’s 
total oxygen while only consisting of 2% of total body weight [11].  
Oxidative stress 
Oxidative stress occurs as reactive oxygen species (ROS) accumulate in the 
cell, either from excessive production or insufficient neutralization, causing damage 
to DNA, lipids, and proteins. The Fenton reaction is a classic method by which toxic 
free radicals are created from hydrogen peroxide and iron as shown in figure 1. 
Hydrogen peroxide and iron are both readily available in neurons making this 
reaction relevant to neurodegenerative disease [12]. 
 
Figure 1: Fenton reaction. This figure shows a schematic of how the Fenton reaction 
creates hydroxyl radicals.  
 
Hydroxyl radicals are highly reactive and cause damage to DNA, lipids, and proteins 
as shown in figure 2. Oxidized DNA, lipids, and proteins all initiate localized damage 
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but eventually trigger downstream signaling cascades inducing apoptosis [13, 14]. 
Since reactive oxygen species (ROS) cause global damage to cells it is important for 
cells and especially neurons, to keep ROS in check with antioxidants.  
 
Figure 2: Cycle of lipid peroxidation. This figure shows a schematic of hydroxyl 
radical propagating lipid peroxidation. 
  
HA14-1 mechanism of mitochondrial oxidative stress (MOS) induction 
 HA14-1 is a unique organic compound designed to compete for Bcl-2 
homology-3 (BH3)-domain binding pockets on pro-survival Bcl-2 protein family 
members (figure 3); essentially mimicking pro-apoptotic BH3-only family members 
[15-17]. The Bcl-2 protein family consists of pro-survival proteins and pro-apoptotic 
proteins; the latter are further classified as multi-domain or BH3-only as shown in 
table 1. BH3-only proteins provoke apoptosis by inhibiting the pro-survival Bcl-2 
family members, like Bcl-2 and Bcl-xL, located on the outer mitochondrial 
membrane. Bax and Bak are the multi-domain pro-apoptotic Bcl-2 family members 
which Bcl-2 and Bcl-xL sequester [18]. The Bcl-2 protein family has complex 
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interactions regulating apoptosis as demonstrated in figure 4. For example, Bcl-2 
inhibits the BH3-only protein tBid from inserting into mitochondrial membranes, 
inducing Bax translocation to the mitochondria, and creating Bax-Bak oligomers 
[19]. The roles of BH3-only proteins are divided into activators and inactivators in a 
highly regulated hierarchy with the purpose of inhibiting Bcl-2 and Bcl-xL to induce 
apoptosis [20]. As a BH3-only mimetic, HA14-1 is pro-apoptotic; more specifically, 
we have shown it to induce mitochondrial oxidative stress (MOS) in neurons [21]. 
 
Figure 3: HA14-1 binds Bcl-2. This figure shows HA14-1 binding to the BH3 
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Figure 4: Pro-apoptotic and anti-apoptotic role of Bcl-2 proteins. This figure shows 
Bim and Bax in their pro-apoptotic role inhibiting Bcl-2 as a part of the intrinsic 
apoptosis cascade. 
 
Mitochondrial oxidative stress (MOS) and dysfunction  
 The mitochondria are the powerhouses of the cell. They have the duty of 
generating cellular energy in the form of ATP. Without ATP the cell will become 
energy deprived and eventually die. The most efficient way for a cell to create ATP is 
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through oxidative phosphorylation in the mitochondria, which uses the electron 
transport chain (ETC). The ETC is not perfect so there is a basal level of electron leak 
under the best of conditions. As shown in figure 5 the leaky electrons are the main 
initiators of ROS. Moreover, ROS produced in mitochondria target the various 
components of the ETC resulting in a feed forward cycle of further ATP depletion 
and enhanced generation of ROS. As a result, mitochondria are both a major source 
and target for ROS.  
 An oxidatively stressed mitochondrion is also a dysfunctional mitochondrion. 
Mitochondria, under these conditions can repair through mitophagy [22], other 
counteracting pathways [23], or can initiate the intrinsic apoptosis pathway. 
Initiating apoptosis is a last resort for the cell, but there are only so many 
compensatory mechanisms available. In addition to ROS production, mitochondrial 
dysfunction also leads to alterations in mitochondrial membrane potential, ATP 
production, and Ca2+ homeostasis. Changes in mitochondrial membrane potential 
and calcium homeostasis can induce the mitochondrial permeability transition pore 
(PTP) which is reversible but can also lead to cell death [24, 25]. It has been shown 
by various research groups, through the use of knockout mouse models, that there 
are many players in the PTP and disagreement exists as to which proteins are 
required for the pore to be formed. However, it is clear that ROS sensitizes the PTP 
to activation by Ca2+, thus oxidative stress plays a key role in pore opening.  
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Figure 5: ETC generation of ROS. This schematic shows the ETC contributes to 
ROS by leaking electrons in their transport through the ETC. Reproduced from:  




If mitochondrial function deteriorates beyond repair the intrinsic apoptosis 
pathway will be initiated as in figure 4. This pathway often begins with the release 
of cytochrome C, one of many apoptosis-inducing factors. Cytochrome C is also a 
regular member of the ETC carrying electrons from complex III to complex IV. 
Cytochrome C release occurs when cardiolipin, its lipid tether, is oxidized making its 
release a direct effect of oxidative stress [26]. When cytochrome C is in the 
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cytoplasm, caspase 9 is activated followed by caspase 3, commonly known as the 
executioner caspase [27].  
 The complex role of MOS and dysfunction in apoptosis and 
neurodegeneration makes the mitochondrion an interesting organelle for 
investigation and its involvement in neurodegeneration has been thoroughly 
reviewed [28-31]. As its role is further understood, the pathways underlying MOS 
and intrinsic apoptosis will increasingly become promising therapeutic targets for 
neurodegenerative diseases.  
There are few treatments currently available for neurodegenerative diseases. 
The treatments that are available only treat symptoms of the disease, not the 
pathology of the disease. For example, riluzole is the only drug available to treat 
ALS. Riluzole may delay the patient’s dependency on a ventilator. However, it is not 
effective in all patients and can only extend life by 3-5 months.  
Endogenous antioxidants 
 ROS created during normal cellular respiration must be neutralized by a 
cell’s antioxidant defenses before these free radicals have the opportunity to 
damage the cell. As previously discussed, ROS become a major problem for the cell 
when there is an imbalance between ROS created and ROS neutralized. As the cell’s 
balance of ROS and antioxidants become disparate, oxidative stress occurs which is 
a damaging phenomenon that will lead to apoptosis. The electron transport chain in 
the mitochondria is a major source of ROS in a cell. For this reason, it is important to 
have antioxidants, like glutathione peroxidase and superoxide dismutase, located 
within the mitochondria.   
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 Glutathione, superoxide dismutase, and other endogenous antioxidants are 
important, but transcription factors for antioxidant genes, like nuclear factor-
erythroid 2-related factor 2 (Nrf2) are also vital players because they initiate an 
antioxidant cascade. In response to oxidative stress, Nrf2 is known to induce a 
variety of antioxidant genes by recognizing an antioxidant response element (ARE) 
binding site within their promoter regions [32]. Some key antioxidant genes turned 
on by Nrf2 include -glutamylcystein ligase (GCL), the rate limiting enzyme in the 
synthesis of GSH, MnSOD, and heme oxygenase, to name a few [33]. As a result this 
pathway has been identified as a promising therapeutic target for 
neurodegenerative diseases [34]. Nrf2 is normally sequestered in the cytoplasm by 
kelch-like ECH associating protein 1 (Keap1). These proteins must be dissociated in 
order for Nrf2 to move into the nucleus and promote gene transcription. The 
mechanism of activating Nrf2 is demonstrated in figure 6 and reviewed by 
Kobayashi and Yamamoto [35].  
  Nrf2 has been meticulously investigated in order to elucidate its role in 
antioxidant gene regulation. It has been shown to be neuroprotective in many 
cellular models. For example, an increase in Nrf2 activity protects SH-SY5Y human 
neuroblastoma cells from oxidative damage induced by the Parkinson’s neurotoxin, 
6-hydroxydopamine (6-OHDA) [36]. 6-OHDA was again used in both in vivo and in 
vitro neuronal models where Nrf2 was protective [37, 38]. Primary cortical neuronal 
cultures from mice are another popular model in which Nrf2 induction has been 
protective against oxidative stress [39, 40]. Finally, Nrf2 activation placated PD 
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symptoms in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse 
model of PD [41].  
 
 
Figure 6: Nrf2/Keap1 antioxidant response element (ARE) pathway. This figure shows 
two ways the transcription factor, Nrf2, can be activated and one of many possible 
gene products and downstream effects. 
 
Nutraceutical antioxidants 
In addition to the cell’s endogenous antioxidant defenses, an organism can 
boost its antioxidant levels through a diet rich in antioxidants. Many foods in a 
common diet, like broccoli, berries, apples, and teas, are full of antioxidants. While 
every antioxidant rich food has a unique antioxidant profile there are a few main 
categories of antioxidants. The flavonoid polyphenols, non-flavonoid polyphenols, 
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phenolic acids, and organosulfur compounds are some of the most well known 
natural antioxidant families.  
The flavonoid polyphenol family is typified by epigallocatechin 3-gallate 
(EGCG), the high profile antioxidant in green tea, and quercetin, abundantly found in 
the skin of apples. The chemical structures of these compounds are found in figure 
7. EGCG has shown significant neuroprotective effects in a variety of in vitro 
paradigms. Previous work in our laboratory has that shown cerebellar granule 
neurons (CGNs) are selectively protected from oxidative stress by EGCG [42]. Other 
studies have reported similar results where EGCG relieved oxidative stress and 
lessened neuronal cell death induced by hydrogen peroxide in motoneurons [43], 
N18D3 mouse neuroblastoma x dorsal root ganglion hybrid cells [44], spiral 
ganglion cells [45], and RGC-5 retinal ganglion cells [46]. In addition to the various 
in vitro studies using EGCG, in vivo neurodegenerative disease models have also seen 
significant effects with EGCG. EGCG treatment prevents the MPTP-induced loss of 
dopamine neurons from the substantia nigra pars compacta and preserves striatal 
dopamine levels in mice [47]. Similarly, in the transgenic mouse model of ALS 
expressing human G93A mutant SOD1 (Cu, Zn-superoxide dismutase) EGCG 
significantly delays symptom onset and somewhat extends life span when compared 
to vehicle treated mice [43, 48]. 
Quercetin is a flavonoid found in many common foods like apples and capers. 
Like EGCG, quercetin has also been extensively studied in in vitro models of 
neuronal death and in vivo neurodegenerative disease models. In vitro studies 
showed that PC12 cells treated with quercetin displayed an increased survival 
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following exposure to hydrogen peroxide [49, 50], linoleic acid hydroperoxide [51], 
or tert-butyl hydroperoxide [52]. In an in vitro Parkinson’s disease model, 1-methyl-
4-phenylpyridinium (MPP+)-induced toxicity of mixed ventral mesencephalon 
cultures were attenuated by quercetin treatment [53]. In vivo models of 
neurodegeneration with quercetin have mostly focused on cognitive impairments, 
ischemia, and traumatic injury. Quercetin improved memory, cognitive 
performance, and hippocampal synaptic placticity in cognitive impairment 
paradigms using colchicine, lipopolysaccharide, or chronic lead exposure [54-56]. In 
an ischemia model, quercetin significantly decreased the size of the ischemic lesion 
[49] and suppressed hippocampal neuronal death [57]. Cumulatively, these studies 
show that quercetin has the potential, like EGCG, to be developed as a therapy for 




Figure 7: EGCG and quercetin structures.  
Non-flavonoid polyphenols are another distinguished group of antioxidants 
that includes curcumin and resveratrol shown in figure 8. Resveratrol, an 
antioxidant generally found in many kinds of grapes is known mostly for its 
cardiovascular benefits but it has also been used to reduce neuronal death in in vitro 
[58] and in vivo models [59, 60]. Research on the non-flavonoid polyphenol 
curcumin is less extensive than that of resveratrol. However, in Neuro2a cells 
infected with Japanese encephalitis, curcumin enhanced cell viability by decreasing 
ROS and pro-apoptotic signals [61]. Curcumin has also been demonstrated to 
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protect rats from brain ischemia [62] and mice from MPTP-induced 
neurodegeneration [63]. In the MPTP study, curcumin exhibited a capacity to block 
glutathione depletion and suppress lipid peroxidation stimulated by MPTP. These, 





Figure 8: Resveratrol and curcumin structures. 
 Phenolic acids are another family of antioxidants. These are found in the 
herb, rosemary. Rosmarinic acid and carnosic acid are the familiar compounds in 
this group (Figure 9). Rosmarinic acid has been shown to scavenge peroxynitrites 
and ROS [64, 65]. As a scavenger, rosmarinic acid has been effective at protecting 
SH-SY5Y human neuroblastoma cells from hydrogen peroxide-induced oxidative 
stress [66]. In vivo studies with mouse models of AD and ALS have shown that 
rosmarinic acid alleviates memory impairment associated with A  neurotoxicity 
and significantly delayed motor dysfunction and prolonged life in the G93A mutant 
SOD1 ALS mouse model [67, 68].  
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Carnosic acid, like rosmarinic acid, has been shown in both in vitro models of 
neuronal death and in vivo neurodegenerative disease models to be 
neuroprotective. In vitro, carnosic acid activates the Keap1/Nrf2 transcriptional 
pathway protecting neurons from oxidative stress [69]. Carnosic acid translocates to 
the brain and increases reduced glutathione levels protecting against middle   




Figure 9: Phenolic acid structures. 
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The last of the well known antioxidant groups to be discussed are the 
organosulfur compounds allicin and l-sulforaphane seen in figure 10. Allicin is found 
in garlic, and garlic extract is used more often than pure allicin in studies. A short 
study using garlic extract on young and old rat brain synaptosomes showed that 
production of 8-iso-prostaglandin F2  (8-iso-PGF) was significantly decreased by 
treatment of garlic extract in the young rat brain under control and hydrogen 
peroxide-induced oxidative stress conditions. The aged rat brain only responded to 
the garlic extract at the highest dose studied and under oxidative stress [70]. 8-iso-
PGF is a modified unsaturated fatty acid released from the plasma membrane under 
oxidative conditions when there are insufficient antioxidants available. In a cell free 
in vitro study, garlic extract inhibited caspase-3 activation; thus garlic would have 
neuroprotective potential because casepase-3 is the executioner caspase in the 
apoptosis cascade [71]. Chauhan [72] reviews the neuroprotective effects of garlic in 
the context of AD.  
L-sulforaphane, an organosulfur compound found in broccoli and other 
cruciferous vegetables has also been used as a neuroprotectant. Dopaminergic 
neurons, which are effected in PD, can be induced to produce toxic dopamine 
quinone and ROS by 6-hydroxydopamine (6OHDA) and tetrahydrobiopterin [73]. 
Dopamine quinone-induced neuronal death can be inhibited by pretreatment with l-
sulforaphane [74]. Additionally, neurons undergoing hydrogen peroxide-induced 
oxidative stress in an astrocyte-neuron mixed culture can be protected through the 
activation of the ARE by Nrf2, which l-sulforaphane has been shown to activate [39]. 
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L-sulforaphane activating this pathway is shown in figure 6. In another primary 
coculture model, l-sulforaphane mitigated dopaminergic neuronal loss from 6-




Figure 10: Organosulfur compound structures. 
It is easy to see that natural antioxidants are gaining popularity and 
credibility. There are many more studies than the ones mentioned here. Natural 
antioxidants and nutraceuticals are increasing their momentum in 
neurodegeneration because these diseases are publicized more than others and 
“natural” is perceived as safer than other treatment plans. In addition, the only 
treatments available for neurodegenerative diseases are palliative; they do not 
attack disease progression, only symptoms of the disease.  
Anthocyanins  
 Anthocyanins are a unique family of natural antioxidants found in many 
fruits and vegetables. Many delicious berries such as blueberries, cranberries, 
19 
chokeberries, and lingonberries, have incredibly different poly-phenolic profiles but 
all have consistently high anthocyanin content [75]. A structural comparison of 
antioxidant families is reviewed by Rice-Evans et al [76] giving a hierarchy of 
antioxidants based on their trolox equivalent antioxidant activities. This ordering 
has many anthocyanins near the top along with other well-known antioxidants like 
EGCG, a potent polyphenolic antioxidant found in green tea. As can be seen in figure 
11 the structures of the two anthocyanins, callistephin, pelargonidin 3-O-glucoside, 
and kuromanin, cyanidin 3-O-glucoside, are extremely similar with only one 
hydroxyl group difference. The ring structures also share some obvious similarities 
to EGCG. Few studies have been conducted to assess the neuroprotective potential 
of anthocyanins. Anthocyanins have been shown to prevent ROS-mediated neuronal 
death in an aging mouse model of D-galactose-induced oxidative stress [77]. 
Another study showed that the same purple sweet potato anthocyanin used in the 
previously mentioned study also improves learning and memory in mice [78]. A 
variety of other in vivo studies in rats have shown that anthocyanins can recover age 
related cerebellar motor function, -adrenergic receptor function, heat shock 
protein 70 responses, and other age related neuronal insufficiencies [79-81].  






Figure 11: Anthocyanin structures. 
Hypothesis and rationale  
 With the recent boom in natural antioxidant research as previously 
discussed, and the consensus that oxidative stress plays a major role in 
neurodegenerative diseases, we thought it would be informative to identify specific 
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nutraceutical antioxidants that are capable of protecting CGNs from MOS-induced 
apoptosis. Oxidative stress has global consequences for the cell, which makes it even 
more important to examine molecular endpoints other than apoptosis such as lipid 
peroxidation and mitochondrial structure and function. These other measures are 
important because a neuron may not have gone through apoptosis but if it still has 
high levels of lipid peroxidation or fragmented mitochondria then the inevitable 
death of the cell, by apoptosis or otherwise, may just be delayed.  
 Heightened antioxidant capacity is a way neurons cope with oxidative stress. 
Therefore, the identification of new compounds that are capable of preventing 
apoptosis in an in vitro neuronal model, as well as inhibiting lipid peroxidation, 
mitochondrial fragmentation, OPA-1 cleavage, and mitochondrial glutathione 
depletion, may provide a foundation for new therapeutic strategies employing 
nutraceutical antioxidants for neurodegenerative diseases.  
Summary of major findings 
 Using CGNs as a model in vitro neuronal system and the Bcl-2 inhibitor, 
HA14-1, to induce MOS, we tested a variety of nutraceutical antioxidants for 
neuroprotection. Of the active compounds, the anthocyanins, callistephin and 
kuromanin, stood out as being powerful antioxidants and neuroprotectants. 
Oxidative stress induces the activation of many damaging pathways in a cell that 
eventually lead to apoptosis. This investigation began by establishing that 
callistephin and kuromanin were equally as good as EGCG at rescuing CGNs from 
MOS-induced apoptosis. When endogenous antioxidant levels were examined, 
mitochondrial glutathione levels were significantly reduced by HA14-1 and this 
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essential antioxidant pool was preserved by callistephin or kuromanin. Lipid 
peroxidation is a major consequence of oxidative stress so a thiobarbituric acid 
reactive substances (TBARS) assay was used to show that callistephin and 
kuromanin could reduce cellular lipid peroxidation. A more specific lipid 
peroxidation study on a key mitochondrial lipid, cardiolipin, was used to show that 
callistephin could prevent HA14-1 from inducing cardiolipin oxidation. Additional 
scrutinization of mitochondrial function was conducted through mitotracker green 
imaging of mitochondrial structure and OPA-1 cleavage. In summary, callistephin 
and kuromanin appear to inhibit apoptosis by preventing glutathione depletion in 
the mitochondria, scavenging lipid radicals, and preventing cleavage of the 
mitochondrial fusion GTPase, OPA-1, in order to maintain normal mitochondrial 








Chapter Two: Materials and Methods 
Reagents  
HA14-1 and glutathione monoethylester were obtained from Calbiochem 
(San Diego, CA). Callistephin chloride, kuromanin chloride, thiobarbituric acid, and 
monoclonal antibody against -tubulin were purchased from Sigma-Aldrich (St. 
Louis, MO). Mitochondria/cytosol fractionation kits were obtained from BioVision 
(Mountain View, CA). GSH/GSSG assay kit was purchased from Oxford Biomedical 
Research (Oxford, MI). Acridine orange 10-nonyl bromide and mitotracker green 
were obtained from Invitrogen (Carlsbad, CA). Trichloroacetic acid was from Fisher 
Scientific (Pittsbugh, PA). Polyclonal antibody against -actin was obtained from 
Cell Signaling (Beverly, MA).  Horseradish peroxidase-linked secondary antibodies 
and reagents for enhanced chemiluminescence detection were from Amersham 
Biosciences (Piscataway, NJ). FITC-conjugated secondary antibody for 
immunofluorescence was from Jackson Immunoresearch Laboratories (West Grove, 
PA).  
CGN culture 
CGNs were isolated from postnatal day 7 Sprague-Dawley rat pups of both 
sexes, as previously described [82]. CGNs were plated on poly-L-lysine coated 
35mm diameter plastic dishes at 4.0 x 106 cells/well in Basal Eagle’s Medium 
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containing 10% fetal bovine serum, 25mM KCl, 2mM L-glutamine, and 
penicillin/streptomycin (100U/ml/100µg/ml). Cytosine arabinoside (10µM) was 
added to the culture medium 24h after plating to limit the growth of nonneuronal 
cells. This protocol produced cultures ~95% pure for granule neurons. Typically, 
experiments were performed after 6-7 days in culture.  
Treatments 
 CGNs were treated with anthocyanins, or other antioxidants, and HA14-1 for 
24 hours for immunocytochemistry and 4 hours for all other experiments.  
Immunocytochemistry 
 CGNs were fixed in 4% paraformaldehyde for one hour followed by a 
blocking solution made of 5% BSA in .2% triton-X PBS for an hour. Once blocked, 
primary antibodies, -tubulin and active caspase 3, were prepared at dilutions 
1:200 and 1:1000, respectively, in 2% BSA .2% triton-X PBS then incubated 
overnight in the refrigerator. Secondary antibodies, conjugated to FITC and Cy3, 
were prepared at 1:250 dilution in 2% BSA .2% triton-X PBS with DAPI at 1:1000 
and incubated for an hour at room temperature. 5 images per well were captured 
for apoptosis quantification.  
Cardiolipin oxidation assay 
 CGNs were treated for four hours and then incubated at room temperature 
with 200µM acridine orange 10-nonyl bromide and Hoechst for 20 minutes then 
washed twice with PBS and imaged immediately under Cy3 and DAPI filters using a 




Mitotracker Green  
 CGNs were treated for four hours and then incubated at 37 degrees Celsius 
for 20 minutes with mitotracker green and Hoechst in Hank’s balanced salt solution 
pH 7.4 and imaged immediately using FITC and DAPI filters with a 40x objective.  
TBARS assay 
 This assay was performed as described below modified from [83-86]. 
Ferrous iron, thiobarbituric acid, and trichloroacetic acid solutions were prepared 
immediately before use with sterile, deionized water flushed with nitrogen gas for 
30min. Seven day old rat pup brain was homogenized and diluted 1:10 (w:v) in 
Kreb’s buffer (pH 7.4). Samples were immediately prepared with 500µl of 
homogenate, callistephin (106µM, 213µM, and 426µM) and kuromanin (103µM, 
206µM, and 412µM) in duplicate, so one sample would have 200µM, final 
concentration, ferrous iron added and one would not. All samples were qued to 
750µl with Kreb’s buffer. Prepared samples were incubated at 37 degrees Celsius 
while shaking for 20 minutes. Then, 300µl of 12.5% trichloroacetic acid in .9N HCl 
was added to each sample to stop the reaction with 70µl of 10% thiobarbituric acid 
in .9N NaOH .9% NaCl solution. Then, samples were boiled for 20 minutes, cooled 
slightly, and centrifuged at 2000rpm for 15 minutes. The supernatant was 
transferred to duplicate wells on a 96 well plate and absorbance was read once per 
minute for ten minutes at 532nm. All readings for a sample were averaged together. 
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Corresponding without iron sample absorbance was subtracted from the with iron 
sample to account for the absorbance of the anthocyanins.  
CGN fractionation 
 After treatment, CGNs were fractionated into mitochondrial and cytosolic 
fractions using a kit from BioVision (Mountain View, CA). Cytosolic and 
mitochondrial buffers were prepared per kit instructions. On ice, CGNs were washed 
once with ice cold 1X-PBS. Then, 200µl of cytosolic buffer was added to each well for 
20 minutes. Wells were scraped and duplicate wells were transferred to 
microcentrifuge tubes. Samples were homogenized (about 40 strokes). In cold room, 
samples were spun at 720 rcf for 10 minutes. Supernatant is transferred to the 
“mitochondrial” tube and spun at 10,000 rcf for 30 minutes. Visible mitochondrial 
pellet should be present. Supernatant is transferred to “cytosolic” tube and pellet 
was resuspended in 100µl mitochondrial buffer.  
Glutathione assay 
 Glutathione assay kit from Oxford Biomedical Research (Oxford, MI) was 
adapted from the manufacturer’s instructions for cuvettes to be used in a 96-well 
plate by proportionally reducing the volume of reagents and sample from 1mL to 
300µL.  
Cell lysis and immunoblotting 
 After treatment, whole-cell lysates of CGNs for Western blotting were 
basically prepared as described previously [87]. Equal amounts of cell protein, as 
determined by a BCA protein assay kit (Pierce Chemical Co., Rockford, IL), were run 
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on a polyacrylamide gel. Proteins were transferred to polyvinylidene difluoride 
(PVDF) membranes for immunoblotting. Membranes were blocked in PBS-T 
containing 1% BSA and .01% sodium azide for 1h at RT. Primary antibodies were 
prepared in blocking solution and incubated with the membrane for 1h. Membranes 
were next washed 5 times over 30min with PBS-T. Secondary antibody prepared in 
PBS-T was incubated with the membrane for 1h at RT. Then, membranes were 









Chapter Three: Results 
Antioxidant screen in MOS-induced death of CGNs 
As there are multitudes of naturally occurring antioxidants it was necessary 
to perform an initial screen in order to determine those that might provide robust 
neuroprotection in our CGN MOS model. As shown in table 2, about half of the 
antioxidants used did not provide any significant protection against MOS-induced 
CGN death. Of the compounds that provided protection, we chose to concentrate on 
callistephin and kuromanin because they are from the same chemical family, 
anthocyanins. Additionally, we have already thoroughly investigated EGCG in the 
CGN model [42], while callistephin and kuromanin have not previously been tested 








Callistephin (106µM) ++ 
*Curcumin (10µM) - 
*EGCG (25µM) ++ 
Kuromanin (206µM) ++ 
*Quercetin (20µM) - 
*Resveratrol (100µM) - 
*Rosmarinic acid (50µM) ++ 
 
*Maximum nontoxic concentration in CGNs 
Table 2: Antioxidant Screen. CGNs co-treated with 15µM HA14-1 and listed natural 
antioxidants for 24 hours. Protection is indicated with (+) or (-) (for comparison 
GSH=+++), determined by percent fragmented nuclei using DAPI staining, n=2 
independent experiments.  
 
Anthocyanins protect CGNs from MOS-induced apoptosis 
 There are many compounds in the anthocyanin family that have radical 
scavenging abilities [88] which is why we chose this family to investigate. 
Callistephin and kuromanin are the two anthocyanins we chose because they are 
commercially available in their pure forms. This makes it easier to compare their 
specific effects, whereas extracts and juices contain many additional unknown 
compounds. Shown in figure 12A, MOS induced by the Bcl-2 inhibitor, HA14-1, 
caused a complete disassembly of the microtubule network in CGNs. This is 
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visualized through immunocytochemistry of -tubulin, shown in green. Also in 
figure 12A, active caspase-3 is shown in red. Active caspase-3 is the executioner 
caspase in the intrinsic apoptosis pathway. The natural antioxidants, EGCG (25µM), 
callistephin (106µM and 213µM), and kuromanin (103µM and 206µM), preserved 
the essential microtubule base of the cytoskeleton and neurites that were lost 
during MOS. Apoptotic nuclei were scored as fragmented or condensed using de-
saturated DAPI images like the ones shown in figure 12B. De-saturated, or 
uncolored, images are used because it is easier to see morphology of the nuclei in a 
black and white image than a colored one. The data from all experiments, n=4, are 
combined and shown in figure 12C as the mean +/- SEM.   Callistephin and 
kuromanin each significantly reduced MOS-induced CGN apoptosis to levels 
comparable to that observed for EGCG. However, neither the anthocyanins nor 




Figure 12A: CGNs co-treated with antioxidants (concentrations indicated), and 15µM 
HA14-1, with 15µM HA14-1 alone, or no treatment (control) for 24 hours. 












Figure 12C: Percent apoptosis for combined experiments from Figure 1A. Apoptotic 
cells are those with condensed or fragmented nuclei. Results are shown as mean +/- 
SEM, n=4.  
*** indicates p<.001 compared to all, ### indicates p<.001 compared to HA14 
treatment, and ++p<.01 compared to other antioxidant treatments. All determined 






Mitochondrial Glutathione plays an essential role in CGN survival 
 After determining that the anthocyanins, callistephin and kuromanin, 
significantly protected CGNs from MOS-induced apoptosis, we next investigated the 
mechanism of this neuroprotection. First, we determined whether glutathione, a 
powerful endogenous antioxidant, was being maintained in the mitochondria by 
anthocyanin treatment during MOS. As shown in figure 13, MOS (HA14-1) 
significantly reduces mitochondrial glutathione content. All of the nutraceuticals 
used sustained glutathione levels in the mitochondria above that observed with 
HA14-1 alone with callistephin and kuromanin being slightly more effective than 
EGCG. The data presented in figure 13 represents the mean +/- SEM, n=8. Thus, the 





Figure 13: CGNs co-treated with antioxidants (concentrations indicated) and 15µM 
HA14-1, 15µM HA14-1 alone or no treatment (control) for 4 hours. Post treatment, 
cells were fractionated using differential centrifugation into mitochondrial and 
cytosolic fractions. Data represented as percent glutathione concentration of control 
in mitochondrial fractions, mean +/- SEM, n=8. * indicates p<.05 when compared to 
HA14 by a two-tailed T-test. ** indicates p<.01 when compared to HA14 by a two-
tailed T-test. *** indicates p<.001 when compared to HA14 by a two-tailed T-test.  
 
Anthocyanins reduce lipid peroxidation in vitro 
 Lipid peroxidation occurs when there are unsaturated fatty acids available to 
hydroxyl radicals as previously discussed and shown in figure 2. Hydroxyl radicals 
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are highly reactive and readily available when a cell is undergoing oxidative stress, 
such as that induced by iron. The thiobarbituric acid-reactive-substances (TBARS) 
assay is a classic way to approximate lipid peroxidation in biological systems [89, 
90]. Therefore, we initially tested the anthocyanins for their ability to inhibit lipid 
peroxidation in a cell free system of rat brain homogenate. As shown in figure 14, 
TBARS are measured by the absorbance of a sample’s supernatant at 532nm. 
Anthocyanins are highly pigmented compounds so it was necessary to adjust the 
assay to account for their interfering absorbencies. Samples of rat brain homogenate 
were prepared in duplicate; one was reacted with iron and one without iron as a 
control for the anthocyanin absorbance at each concentration. The anthocyanin 
absorbance at each concentration was subtracted from the corresponding sample 
that was reacted with iron. Figure 14 shows the mean +/- SEM, (n=4) of the 
calculated absorbencies. Both callistephin and kuromanin each caused a dose 
dependent reduction in lipid peroxidation induced by iron. The approximately 





Figure 14: Rat whole brains were homogenized and treated with callistephin, 
kuromanin (at the concentrations indicated) or no treatment (control). Lipid 
peroxidation was induced using 200µM ferrous iron and assayed for TBARS 
absorbance at 532nM. Higher absorbance indicates increased levels of lipid 
peroxidation. Data represented as mean +/- SE, n=4. ** indicates p<.01 post hoc 
Tukey’s test. ### indicates p<.001 post hoc Tukey’s test. 
 
Cardiolipin oxidation induced by MOS in CGNs is reduced by callistephin 
 The TBARS assay showed that the anthocyanins are capable of inhibiting 
lipid peroxidation in vitro in rat brain homogenates. In the neuronal cell model used, 
CGNs and HA14-1, mitochondria are specifically targeted so an assay to specifically 
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assess the oxidation of mitochondrial lipids will yield more relevant information. 
Cardiolipin is a lipid found nearly exclusively in mitochondrial membranes [91]. It 
plays an important role in tethering cytochrome C to the inner mitochondrial 
membrane and preventing its release from mitochondria. Indeed, cytochrome C 
release in apoptosis is linked to cardiolipin peroxidation [26, 92, 93]. Peroxidation 
of cardiolipin can be assessed through binding of the fluorescent dye acridine 
orange 10-nonyl bromide (AO) [94]. AO binds to reduced cardiolipin and the dye is 
released when cardiolipin is oxidized making it easy to visualize. Untreated 
(control) CGNs have a very bright AO fluorescence as do the (HA14-1 + 
callistephin)-treated CGNs indicative of substantial amounts of reduced cardiolipin 
in the mitochondrial membranes. CGNs treated with HA14-1 and therefore, 
undergoing MOS, fluoresce very dimly in comparison at the same exposure time. 
The dim fluorescence indicates that most of the cardiolipin has been oxidized (figure 
15). The images presented in figure 15 are representative images of all experiments 
performed, n=3. These data indicate that MOS-induced CGN death in associated with 





Figure 15: CGNs co-treated with 426µM callistephin and 15µM HA14-1, 15µM HA14-
1 alone, or no treatment (control). Cells were stained with acridine orange 10-nonyl 
bromide (AO). AO binds exclusively to cardiolipin and is released when cardiolipin 
is oxidized. AO fluorescence shown in red and Hoechst nuclear staining shown in 
blue, n=3. Scale bar = 10µm. 
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Mitochondrial disassembly induced by MOS in CGNs is prevented by 
callistephin 
 
 After seeing a difference in cardiolipin peroxidation between HA14-1 and 
HA14-1 with callistephin, mitochondrial morphology was investigated using 
Mitotracker Green. Mitotracker is accumulated selectively in the mitochondria of the 
cell and allows visualization of mitochondrial structure. In the control CGNs and  
(HA14-1 + callistephin)-treated CGNs, the mitochondria appear long tubular, and 
connected. In contrast, CGNs treated with HA14-1 alone have mitochondria that 
appear punctate and disconnected. Both of these morphologies are shown in figure 
16A. These images are representative of all experiments performed, n=3. 
Mitochondria are dynamic organelles, constantly undergoing fission and fusion. A 
key fusion protein, OPA-1, has a unique, nonfunctioning, cleavage product present 
during apoptosis[95]. Figure 16B shows a western blot of OPA-1. The cleavage 
product is present in the HA14-1 lane and is reduced or eliminated in the lanes 
where the CGNs had been treated with HA14-1 and either callistephin or 
kuromanin. Below the OPA-1 blot, a blot of -tubulin is shown to ensure equal 
protein loading in all lanes. Collectively, these data suggest that MOS induces 
cleavage of OPA-1 and enhanced mitochondrial fission or fragmentation; both of 




Figure 16A: CGNs treated as in Figure 15. Cells were stained using mitotracker green 






Figure16B: CGNs co-treated with callistephin and 15µM HA14-1, kuromanin and 15µm 
HA14-1, 15µM HA14-1 alone, or no treatment (control) for 4 hours. Post treatment cells 
were lysed using 1% Triton X-100 and western blots were completed for OPA1. Asterisk 
indicates presence of OPA1 cleavage product. -tubulin indicated loading control, n=3. * 










Chapter Four: Discussion 
 In the beginning of these experiments it was frustrating to find so many 
natural products that did not provide protection to the CGNs against HA14-1 (MOS-
induced) death when they had been shown to work so well in other in vitro 
neurodegenerative models. Our model targets the mitochondrial oxidative stress 
specifically; whereas other in vitro models of oxidative stress are less organelle-
specific. Also, the previous studies were not done in CGNs. These differences in 
neurodegenerative models are probably why some of the antioxidants protected 
well and others including, curcumin, quercetin, and resveratrol, did not protect the 
CGNs from mitochondrial oxidative stress. It was determined that the anthocyanins 
provided strong, consistent neuroprotection in the CGN model. Once we were 
satisfied that the anthocyanins rescued CGNs from HA14-1 (MOS-induced) 
apoptosis, we were able to look into the cellular mechanisms that are disrupted 
under oxidative stress.  
 Glutathione (GSH) is a prevalent antioxidant in mitochondria and its 
availability is key to keeping up with the necessary neutralization of ROS. For this 
reason, we looked specifically at the mitochondrial GSH levels of CGNs after 4 hours 
of treatment. As expected, HA14-1 treatment reduced the amount of GSH in the 
mitochondria. Since HA14-1 binds to the BH3-only domain on Bcl-2 and GSH also is 
 
44 
predicted to bind to that same pocket [21], it is not surprising that HA14-1 would 
have a negative effect on the mitochondrial pool of GSH. It is encouraging that 
callistephin and kuromanin were able to partially restore this key pool of 
mitochondrial GSH. MOS is an underlying problem in neurodegenerative disease so 
it is imperative that potential nutraceutical therapies be able to preserve or restore 
the mitochondrial pool of GSH, as observed for callistephin and kuromanin. 
 TBARS is a classic assay used to measure membrane lipid peroxidation, 
which is why we chose it to begin the investigation into the state of the lipids in our 
model MOS system. Anthocyanins are a highly pigmented family and they are what 
give berries and other red foods their color [86]. As a result, callistephin and 
kuromanin have a large amount of interfering absorbance at 532nm. To account for 
this interference, we simply had a non-reacting sample for each concentration of 
anthocyanin used to subtract from the reacting sample. We found that both 
callistephin and kuromanin were excellent at preventing thiobarbituric acid reactive 
substances from being created in rat brain homogenates. This is important for the 
stability of the neurons because lipid peroxidation can change mitochondrial 
membrane potential inducing PTP activation.  
 After seeing that both callistephin and kuromanin could prevent lipid 
peroxidation in a global assay like TBARS, we narrowed in on a mitochondrial lipid, 
cardiolipin. Cardiolipin is an integral part of the inner mitochondrial membrane and 
is key in tethering cytochrome C to the ETC. Cardiolipin’s role in cytochrome C 
release makes its oxidation specifically important in assessing neuronal health and 
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as a therapeutic target [96]. Therefore, the fact that callistephin was able to block 
cardiolipin oxidation is important to its potential future use therapeutically. As seen 
in figure 15, kuromanin is notably absent from the panel. Kuromanin did not 
necessarily fail to prevent cardiolipin oxidation, but the color of kuromanin seemed 
to interfere with the AO fluorescence so images could not be collected. This may 
indicate that kuromanin somehow quenched the fluorescence of AO. 
 Similarly to looking at cardiolipin oxidation, Mitotracker Green focuses on 
the mitochondria. It is used to examine mitochondrial structure, which is critical to 
well functioning mitochondria. The images show a distinct difference between the 
mitochondria of HA14-1 treated CGNs and the mitochondria of CGNs co-treated with 
callistephin and HA14-1. The co-treated CGNs show mitochondria that are long and 
tubular which is the expected structure. Proper mitochondrial structure can be 
indicative of overall neuronal health. Since neurons are more sensitive to MOS 
induced death than other cell types, mitochondrial structure is an important index 
of health. Analogous to the cardiolipin assay, kuromanin imaging was not possible 
due to color interference. OPA-1 cleavage products are another way to assess 
mitochondrial structure and function because OPA-1 is necessary for mitochondrial 
fusion. The cleavage product in the HA14-1 treatment is a non-functioning product 
because the GTPase domain is absent [95]. When mitochondria are only able to 
undergo fission, they become smaller and smaller until the mitochondria are 
inefficient fragments. These fragmented mitochondria are not able to support the 
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cellular energy needs in addition to the fact that inefficient mitochondria have 
excessive ETC leak, increasing ROS.  
 In summary, the anthocyanins, callistephin and kuromanin, have proven to 
be effective nutraceutical antioxidants in our MOS-induced CGN apoptosis model. 
Figure 17 shows that these nutraceuticals block mitochondrial glutathione depletion 
and cardiolipin/lipid peroxidation, prevent OPA-1 cleavage and maintain 
mitochondrial structure. These nutraceuticals have an overall effect of preventing 
MOS and therefore MOS-induced apoptosis. The multitude of palliative effects that 
the anthocyanins have on MOS-related cellular deficiencies will make them excellent 
candidates for future use with in vivo neurodegenerative disease models.  
 
 Figure 17: Summary schematic. This schematic shows how callistephin and 
kuromanin act as nutraceutical antioxidants to block MOS-induced death, 




 In the future, we would like to use these compounds in a glutathione 
peroxidase assay to see if the increase in the mitochondrial glutathione pool is a 
result of increased turnover of GSSG/GSH. Glutathione must be recycled back to its 
reduced form in order to continue its antioxidant effects. This assay will provide 
important information as to the mechanism of neuroprotection of the anthocyanins. 
Glutathione reductase is used to convert GSSG back to functional GSH. GSH 
peroxidase activity is measured in an activity assay coupled to GSH reductase 
function. Thus, an increase in GSH peroxidase activity in the presence of 
anthocyanins will indicate an enhancement of GSH recycling.   
Glutathione peroxidase, a phase II enzyme, is not the only way to increase the 
antioxidant capacity of a cell. There are many phase II enzymes whose genes have 
an antioxidant response element (ARE). Many endogenous antioxidants and phase II 
enzymes, like γ-glutamylcysteine ligase, MnSOD, and heme oxygenase, are regulated 
by an ARE on their genes. Nrf2 is a transcription factor that regulates ARE genes. A 
study investigating the activation of phase II enzymes by anthocyanins showed that 
anthocyanins, including kuromanin, up-regulated the production of 
NAD(P)H:quinone oxidoreductase 1 (NQO1), a phase II enzyme [97]. This up-
regulation demonstrates that anthocyanins can activate Nrf2 because Nrf2 is a 
necessary transcription factor for the nqo1 promoter. Nrf2 activation can have huge 
effects on the antioxidant capacity of a cell because it is a transcription factor for 
many genes coding for antioxidant enzymes. The more antioxidant functions a 
compound has the greater the effect it will have on reducing oxidative stress in the 
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cell. If the anthocyanin family can both scavenge free radicals and induce 
antioxidant enzyme up-regulation, they have a greater potential to be transitioned 
into nutraceutical use for neurodegenerative diseases.  
We also would like to take these compounds into an in vivo model of 
neurodegeneration, which involves MOS, like the G93A mutant SOD1 transgenic 
mouse model of ALS. In a study using acai berry pulp, which includes anthocyanins, 
phenols, and flavonoids, Swiss albino mice were given between 3.33 g/kg b.w. and 
16.67 g/kg b.w. of the pulp and doxorubicin, to induce DNA damage [98]. For a 
person to consume this amount, they would have to eat about a pound of acai pulp. 
This study did see a significant decrease in DNA damage in blood, liver, and kidney 
cells post euthanasia of the mice. It will be exciting to see if nutraceuticals can have 
significant effects in an ALS mouse model by delaying onset and extending life span 
of the mice. Nutraceutical antioxidants have a promising future in the treatment of 
neurodegenerative diseases because of the relationship between these diseases and 
mitochondrial oxidative stress. Anthocyanins and other nutraceuticals that mitigate 
MOS-induced neuronal death will hopefully have a place one day in the treatment 
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